Skip to main content

Balchem Corporation

corporate_fare Company Profile

Balchem Corporation

BCPC·NASDAQ·Industrial Applications And Services·CIK 0000009326

Balchem Corporation, incorporated in Maryland in 1967, develops, manufactures, distributes, and markets specialty performance ingredients and products. These products serve the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. The company operates through three reportable segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Sales and production from activities outside these segments and other minor business activities are categorized as "Other and Unallocated." Balchem sells its products through its own sales force, independent distributors, and sales agents. The Human Nutrition and Health (HNH) segment offers human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. Choline is recognized for its role in the development and structural integrity of brain cell membranes in infants, processing dietary fat, reproductive development, and neural functions like memory and muscle function. The company's mineral amino acid chelates, specialized mineral salts, and mineral complexes are used as raw materials in premier human nutrition products. Proprietary technologies are used to create organic molecules in a form the body can readily assimilate. Sales growth in human nutrition applications depends on differentiating products from lower-cost competitors through scientific data, intellectual property, and customer brand appreciation.

Balchem Corporation (NASDAQ:BCPC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 7 items for BCPC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-31, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for BCPC spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Balchem Q2 2026: Sales Jump 11% to $284M, EPS $1.39; Credit Facility Expanded to $650M
  • Balchem Q2 Earnings: Record Sales and a Broad-Based Beat Across All Segments
  • Balchem Q2 Sales Surge 11%, Crushing Estimates Across All Segments
  • Balchem Reports Record Q1 2026 Financial Results with Strong Sales and Earnings Growth Across All Segments
  • Balchem's Q1 Sales Jump 8%, Beats Estimates with Strong EPS Growth Across All Segments

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.04B
Net Income
$154.84M
Diluted EPS
$4.75
Op. Cash Flow
$216.56M
Gross Profit
$370.63M
Operating Income
$209.33M
Cash & Equivalents
$74.57M
Debt / Equity
0.00×
Net Margin
14.9%
Shares Outstanding
32.06M sh
Source: 10-K · filed 2026-02-20 · accession 0000009326-26-000007

Short Interest & Short Volume

3.30 days to cover

FINRA reported short interest of 620,041 shares in BCPC as of the September 15, 2026 settlement, a 11.8% increase from the prior period — about 3.3 days to cover at its recent average daily volume. On October 2, 2026, 57.3% of BCPC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)620,041 shares as of September 15, 2026
Change vs prior period▲ 11.8%
Days to cover3.30 at avg daily volume of 187,775
Daily short volume (FINRA facilities)57.3% of 72,071 shares on October 2, 2026
5-day average short volume44.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$166.56
52-week range · as of 2026-07-31 $139.17 – $183.9
Market cap
$5.31B
Volume
197.3K (1.0× avg)
3-mo avg 206.5K
Live data · 2026-10-03 08:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BCPC - Latest Insights

BCPC
Jul 31, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $167.56
Real-time Price: $166.56 info
Change: -$0.995 (-0.59%) info
Market Cap: $5.31B info
BCPC
Jul 31, 2026, 7:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $163.50
Real-time Price: $166.56 info
Change: +$3.06 (+2%) info
Market Cap: $5.31B info
BCPC
Jul 31, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $163.50
Real-time Price: $166.56 info
Change: +$3.06 (+2%) info
Market Cap: $5.31B info
BCPC
Apr 30, 2026, 7:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $166.56 info
Change: -$6.77 (-4%) info
Market Cap: $5.31B info
BCPC
Apr 30, 2026, 7:25 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $166.56 info
Change: -$6.77 (-4%) info
Market Cap: $5.31B info
BCPC
Feb 20, 2026, 4:26 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $166.56 info
Change: -$5.44 (-3%) info
Market Cap: $5.31B info
BCPC
Feb 20, 2026, 7:38 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $175.00
Real-time Price: $166.56 info
Change: -$8.44 (-5%) info
Market Cap: $5.31B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets